- Healthcare Professionals
- Latest research
- Clinical trials
- UTX-TGR-205
UTX-TGR-205
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 and TGR-1202 Alone in Patients With Previously Treated Diffuse Large B-Cell Lymphoma (UNITY-DLBCL)
Trial overview
Topic
UTX-TGR-205
Description
This research study will evaluate the safety and efficacy of a study drug called TGR-1202 in combination with another study drug called ublituximab compared to TGR-1202 alone as a possible treatment for Diffuse Large B-cell Lymphoma (DLBCL).
Physicians
Contact
North Florida / Jacksonville
Maddie Hamilton